Company news
Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A (SSE:600488) news
Tianjin Tianyao Pharmaceuticals Co., Ltd. Class A news releases on 6ix. Latest, Jun 26, 2025: Announcement on Resolution of the 17th Meeting of the 9th Board…
Press releases — page 2
Announcement on Resolution of the 17th Meeting of the 9th Board of Directors
June 25, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 5, 2025
Announcement on Outline of the 2024 Annual Performance Briefing
May 16, 2025
Announcement on Reply to Letter of Inquiry on Post Audit of 2024 Annual Report
May 12, 2025
Announcement on Convening the 2024 Annual Performance Briefing
May 8, 2025
Announcement on Receiving Decision for Administrative Penalty
April 30, 2025
Announcement on Provision for Impairment
April 28, 2025
Announcement on Resolution of the 2024 Annual General Meeting
April 16, 2025
Announcement on Renewing Engagement of Accounting Firm
March 26, 2025
Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection
March 12, 2025